A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer
M. C. Alonso, J. M. Tabernero, B. Ojeda, M. Llanos, C. Solà, M. A. Climent, M. A. Seguí, J. J. López
Research output: Contribution to journal › Article › Research › peer-review
Fingerprint
Dive into the research topics of 'A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer'. Together they form a unique fingerprint.